T16	Exp 69 103	the insulin gene promoter activity
T17	Exp 306 325	the insulin content
T18	Exp 329 338	the cells
T19	Exp 463 465	we
T20	Exp 369 402	the pathophysiological background
T21	Exp 406 436	the so-called glucose toxicity
T22	Exp 572 583	the effects
T23	Exp 662 666	that
T24	Exp 839 843	when
T25	Exp 615 626	The results
T26	Exp 667 692	the insulin gene promoter
T27	Exp 729 765	the control beta-actin gene promoter
T28	Exp 795 829	the insulin gene promoter activity
T29	Exp 844 853	the cells
T30	Exp 875 887	the presence
T31	Exp 964 980	the insulin mRNA
T32	Exp 1017 1044	the glycation-induced cells
T33	Exp 1126 1150	the DNA-binding activity
T34	Exp 1364 1368	that
T35	Exp 1426 1448	the glycation reaction
T36	Exp 1472 1485	the phenomena
T37	Exp 1210 1223	These effects
T38	Exp 1514 1518	that
T39	Exp 1563 1568	which
T40	Exp 1680 1710	the beta cell glucose toxicity
T41	Exp 1487 1505	These observations
R2	Coref Anaphora:T39 Antecedent:T42
T1	Protein 73 80	insulin
T2	Protein 158 165	insulin
T3	Protein 231 238	insulin
T4	Protein 587 594	insulin
T5	Protein 671 678	insulin
T6	Protein 741 751	beta-actin
T7	Protein 799 806	insulin
T8	Protein 968 975	insulin
T9	Protein 985 992	insulin
T10	Protein 1157 1190	insulin gene transcription factor
T11	Protein 1192 1197	PDX-1
T12	Protein 1198 1202	IPF1
T13	Protein 1203 1208	STF-1
T14	Protein 1624 1631	insulin
T42	Exp 1540 1561	pancreatic beta cells
